<--- Back to Details
First PageDocument Content
Biology / Botulinum toxin / Structured Product Labeling / Allergan / Botulism / Spasmodic torticollis / Federal Food /  Drug /  and Cosmetic Act / Center for Drug Evaluation and Research / Biologic License Application / Medicine / Food and Drug Administration / Health
Date: 2009-08-07 11:32:47
Biology
Botulinum toxin
Structured Product Labeling
Allergan
Botulism
Spasmodic torticollis
Federal Food
Drug
and Cosmetic Act
Center for Drug Evaluation and Research
Biologic License Application
Medicine
Food and Drug Administration
Health

DOCUMENT INFORMATION PAGE

Add to Reading List

Source URL: www.accessdata.fda.gov

Download Document from Source Website

File Size: 271,76 KB

Share Document on Facebook

Similar Documents

NEWS The Cosmetics Industry OVERVIEW In the United States cosmetics are officially regulated by the Food & Drug Administration as a result of the Food, Drug and Cosmetic Act passed inThere is also a self-regulato

DocID: 1uASt - View Document

Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act Guidance for Industry

DocID: 1tBOU - View Document

Smoking / Tobacco control / Health / Food and Drug Administration / Tobacco / Electronic cigarettes / Smoking cessation / Food law / Cigarette / Federal Food /  Drug /  and Cosmetic Act / Premarket tobacco application / Regulation of tobacco by the U.S. Food and Drug Administration

RETAIL COMPLIANCE CHECK INSPECTIONS AND FDA ACTIONS: AN OVERVIEW FOR TOBACCO RETAILERS Presented by Michelle Jackson

DocID: 1roDS - View Document

Food and Drug Administration / Health / Food law / Pharmaceuticals policy / Personal life / Pharmaceutical industry / Healthcare quality / Federal Food /  Drug /  and Cosmetic Act / Medical device / Validation / Center for Devices and Radiological Health / RNA-Seq

Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases - Draft Guidance for Stakeholders and Food and Drug Administration

DocID: 1rmMY - View Document

Health / Medicine / Medical technology / Food and Drug Administration / Medical device / Medical equipment / Investigational device exemption / Electronic health record / Interoperability / Federal Food /  Drug /  and Cosmetic Act / Interface / Biomedical engineering

Design Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices - Draft Guidance for Industry and Food and Drug Administration Staff

DocID: 1r7Xt - View Document